Extreme Movers: Perplexity's picks for 2026-11-03

Perplexity picked IDXX, HWM, LITE, MRVL, VG for a 1-day horizon. Average directional return: -1.75%. Directions called correctly: 40%.

ExperimentExtreme Movers
ModelPerplexity
Prompt versionextreme-movers-v11
Asked
Horizon1-day
Measured from2026-11-03
Measured to2026-11-04
BenchmarkSPY
StatusSettled
Average directional return-1.75%
Directions called correctly40%
Benchmark return+1.82%

The picks

RankSymbolDirectionPrice changeReturn in the called directionConfidencevs benchmarkCalled right
1IDXXup+4.12%+4.12%62%+2.31%Yes
2HWMup-2.94%-2.94%58%-4.76%No
3LITEup-8.09%-8.09%55%-9.91%No
4MRVLdown-4.46%+4.46%57%+2.64%Yes
5VGup-6.31%-6.31%52%-8.12%No

The model's market view

The source session was Monday, November 2, 2026. Broad technology weakness coexisted with strong single-stock earnings reactions: IDEXX and Howmet rallied on fundamental results, while Marvell and Lumentum sold off on a large all-stock acquisition. For the next session, I favor selective continuation in fundamentally supported gainers, a rebound in Lumentum after its merger-driven decline, continued pressure in Marvell, and a rebound in Venture Global after an operationally positive but oversold session.

Why each pick

IDXX

IDEXX was the S&P 500's leading gainer in the source session, rising 21.85% after a Q3 beat and raised 2026 revenue and EPS guidance; UBS and Morgan Stanley subsequently raised price targets. The catalyst is substantive, and the pre-market quote was only modestly lower, supporting continuation rather than an immediate fade. Risks are the size of the one-day move, elevated valuation, and profit-taking after an earnings gap. I used the November 3 pre-market quote of $670.02; the 20-day average dollar volume was not independently verified, though the source session's roughly 1.98 million shares at about $672 implies well over the $20 million liquidity floor.

HWM

Howmet gained 6.91% in the source session, extending momentum from its late-October beat-and-raise quarter, and KeyBanc upgraded the shares to Overweight after the report. The catalyst is substantive: Q3 revenue rose 29%, guidance was raised, and the board expanded its buyback authorization. I expect continuation, though the stock remains sensitive to aerospace valuation and broad risk appetite. The reference price is the November 2 after-hours quote of $214.59; the 20-day average dollar volume was not independently verified, but source-session volume of about 5.32 million shares at roughly $213 implies liquidity far above the floor.

LITE

Lumentum fell 18.59% in the source session after Marvell announced a roughly $115 billion all-stock acquisition, with investor concern centered on deal structure and AI-infrastructure valuation. Because the decline was deal-specific rather than a deterioration in Lumentum's standalone outlook, and Raymond James upgraded the shares to Strong Buy afterward, I expect a partial reversal higher. The main risk is that continued skepticism about the merger, or a further decline in Marvell shares, keeps pressure on Lumentum because the consideration is stock-based. The reference price is the latest intraday quote found, $689.85 at 3:28 PM ET on November 2, which is stale relative to the current session; the 20-day average dollar volume was not independently verified, although source-session volume of about 12.6 million shares at roughly $690 implies very large dollar turnover.

MRVL

Marvell dropped 12.72% after announcing the $115 billion all-stock acquisition of Lumentum. The negative reaction was followed by downgrades from TD Cowen and BofA citing dilution, integration, and deal-overhang concerns, making this a substantive rather than merely speculative catalyst. I expect continuation lower, although a stabilization in Lumentum or a broader semiconductor rebound could produce a sharp bounce. The reference price is the November 3 pre-market quote of $175.44; the 20-day average dollar volume was not independently verified, but source-session volume of about 61.5 million shares at roughly $171 implies liquidity far above the floor.

VG

Venture Global declined 12.98% in the source session despite announcing that Phase One of Plaquemines LNG began commercial operations and long-term shipments started. That operational milestone is substantive and supports a rebound, particularly given the stock's low forward earnings multiple and Buy consensus. The risk is that the sell-off reflected concerns about LNG pricing, contract disputes, or execution that outweighed the positive operational news. The reference price is the latest quote found, $14.09 at 10:27 AM ET on November 2, which is stale; the 20-day average dollar volume was not independently verified, although source-session volume of about 4.25 million shares at roughly $14 implies more than $59 million in dollar turnover.

Other models on the same run

ModelPicksAverage directional returnDirections called correctly
Claude Sonnet 5.5IDXX, LITE, OKTA, NXT, CHKP-3.30%40%
Claude Opus 5.5APA, INTC, CIEN, IDXX, ORCL-0.14%40%
GPT-6MRVL, NXT, NWL, LITE, IDXX-0.79%40%
Muse Spark 1.1AEHR, FN, DT, IT, BETA+0.54%40%
Gemini 2.5 FlashIDXX, MRVL, LITE, INTC, PNR-0.14%60%
Grok 4.7IDXX, NXT, LITE, MRVL, ORCL+2.69%80%
GPT-6.1 SolIDXX, MRVL, HWM, LITE, INTC+1.95%60%
API Claude Sonnet 5.5IDXX, LITE, UAL, DASH, ORCL-3.52%20%

Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-11-03.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.